Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
- Conditions
- Anxiety Disorders
- Registration Number
- NCT00214994
- Lead Sponsor
- Cephalon
- Brief Summary
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (89)
Birmingham Research Group
🇺🇸Birmingham, Alabama, United States
Pivotal Research Center
🇺🇸Mesa, Arizona, United States
Pivotal Research
🇺🇸Peoria, Arizona, United States
Southwestern Research
🇺🇸Beverly Hills, California, United States
Valley Clinical Research
🇺🇸El Centro, California, United States
Irvine Center for Clinical Res
🇺🇸Irvine, California, United States
Pharmacology Research Institute
🇺🇸Riverside, California, United States
Pacific Institue for Medical
🇺🇸Los Angeles, California, United States
Pacific Clinical Research Medi
🇺🇸Orange, California, United States
Affiliated Research Institute
🇺🇸San Diego, California, United States
Scroll for more (79 remaining)Birmingham Research Group🇺🇸Birmingham, Alabama, United States